• 👋 Hi, I’m Evan Peikon. I'm a computational biologist and bioengineer whose work spans precision oncology, biodefense, and human performance.
• 🧪 In 2020, I co-founded NNOXX, a spin-out from the Harrington Discovery Institute at Case Western, where I currently work on developing novel digital and molecular biosensors and multi-modal data analysis frameworks.
• 🧬 I'm also a PhD student at George Mason University, where my research focus is on developing developing computational models to understand cancer evolution and mechanisms of treatment resistance with the goal of better personalizing therapies for cancer patients.
• 💀 You can find my writing at Sequence & Destroy, where I share what I'm currently learning, working on, and thinking about.
• 📬 You can reach me at evanpeikon@gmail.com
•